Published in Br Med J (Clin Res Ed) on July 11, 1981
Contemporary issues: diseases with a food vector. Clin Microbiol Rev (1988) 1.31
Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ (1990) 1.02
Acute ileitis. Br Med J (Clin Res Ed) (1981) 0.91
Follow-up study of Reiter's disease and reactive arthritis. Factors influencing the natural course and the prognosis. Clin Rheumatol (1987) 0.79
Yersinia arthritis with erythema nodosum. Postgrad Med J (1986) 0.75
Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand (1969) 4.03
Many bacterial species are mitogenic for human blood B lymphocytes. Scand J Immunol (1978) 2.37
Relation between HLA-B27 and clinical features in patients with yersinia arthritis. Arthritis Rheum (1977) 1.48
Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46
Arthritis associated with Yersinia enterocolitica infections. Scand J Infect Dis (1975) 1.24
Clinical symptoms of infection with Yersinia enterocolitica. Scand J Infect Dis (1971) 1.22
Polyarthritis associated with Yersinia enterocolitica infection. Clinical features and laboratory findings in nine cases with severe joint symptoms. Ann Rheum Dis (1972) 1.21
Follow-up studies of joint complications in yersiniosis. Acta Med Scand (1979) 1.09
[Yersinia arthritis and chronic collagenosis. II. Cases of Yersinia arthritis with prolonged course and development of rheumatoid arthritis]. Ugeskr Laeger (1977) 1.03
A pilot clinical study on yersinioses in South-Eastern Finland. Acta Med Scand (1972) 0.98
[Infections caused by Yersinia enterocolitica: bacteriological, serological, epidemiological and immunological findings in 51 cases (author's transl)]. Dtsch Med Wochenschr (1979) 0.97
HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis. J Rheumatol Suppl (1977) 0.89
Immune responses in yersinia-associated reactive arthritis. Ann Rheum Dis (1979) 0.87
[Yersinia arthritis. A clinical and serological follow-up examination]. Tidsskr Nor Laegeforen (1978) 0.87
Yersinia-induced arthritis and Reiter's syndrome. Ann Rheum Dis (1979) 0.86
[Yersinia enterocolitica infections and their most frequent complications]. Ugeskr Laeger (1977) 0.81
The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva. J Exp Med (1966) 3.97
Yersinia enterocolitica (Pasteurella x) in human enteric infections. Br Med J (1966) 3.87
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum (1988) 2.77
Sensitized sheep red cells as a reactant for Staphylococcus aureus protein A. Methodology and epidemiology with special reference to weakly reacting methicillin-resistant strains. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 2.49
Studies on the interaction between different O-serotypes of Yersinia enterocolitica and HeLa cells. Acta Pathol Microbiol Scand B (1979) 2.20
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Arthritis Rheum (1994) 1.83
Sequential changes of plasma proteins after myocardial infarction. Scand J Clin Lab Invest Suppl (1972) 1.79
Plasma protein constituents of amyloid fibrils. J Immunol (1967) 1.70
Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis (1996) 1.64
Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann Rheum Dis (1986) 1.60
Studies on the macroglobulins of human serum. I. Polyclonal immunoglobulin class M (IgM) increase in infectious mononucleosis. N Engl J Med (1966) 1.55
Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis. Am J Med (1990) 1.47
D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study. Clin Exp Rheumatol (1997) 1.44
Early rheumatoid arthritis--onset, course, and outcome over 2 years. Rheumatol Int (1990) 1.41
Sero-typing of mycobacteria by a new technique using antibody globulin adsorbed to staphylococcal protein A. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.39
[Threatened future of plasma products. Who is responsible?]. Lakartidningen (1996) 1.39
Immunoglobulin studies in six kindreds of patients with adult hypogammaglobulinemia. J Lab Clin Med (1965) 1.38
Disease modifying drugs in rheumatoid arthritis. BMJ (1997) 1.37
Light-chain disease. An abortive variant of multiple myeloma. Ann Intern Med (1966) 1.34
Sudden death in rheumatoid arthritis with atlanto-axial dislocation. Acta Med Scand (1975) 1.32
Direct assessment of synovial blood flow and its relation to induced hydrostatic pressure changes. Ann Rheum Dis (1989) 1.31
The IgA system. II. The clinical significance of IgA deficiency: studies in patients with agammaglobulinemia and ataxia-telangiectasia. Am J Med (1968) 1.29
Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet (1985) 1.28
Arthritis associated with Yersinia enterocolitica infections. Scand J Infect Dis (1975) 1.24
Glomerulonephritis in infections with Yersinia enterocolitica O-serotype 3. I. Evidence for glomerular involvement in acute cases of yersiniosis. Acta Med Scand (1981) 1.23
Clinical symptoms of infection with Yersinia enterocolitica. Scand J Infect Dis (1971) 1.22
Measurement of synovial fluid volume using albumin dilution upon intraarticular saline injection. J Rheumatol (1988) 1.18
Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol (1989) 1.18
Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol (1999) 1.15
Two further cases, bacteriologically verified, of human infection with "Pasteurella X" (syn. Yersinia enterocolitica). Acta Pathol Microbiol Scand (1966) 1.15
Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment. Arthritis Rheum (1987) 1.14
Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study. Rheumatology (Oxford) (2001) 1.14
Clinical aspects on 64 cases of juvenile and adult listeriosis in Sweden. Acta Med Scand (1978) 1.14
Clinical aspects of osseointegration in joint replacement. A histological study of titanium implants. J Bone Joint Surg Br (1988) 1.12
Immunoassay of P-component in amyloidotic sera. Proc Soc Exp Biol Med (1967) 1.10
Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor. Ann Rheum Dis (1990) 1.08
Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science (1983) 1.07
The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis--no relationship with erosions or disease activity. J Rheumatol (1988) 1.04
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement. Rheumatology (Oxford) (2000) 1.04
Differentiation of Yersinia enterocolitica strains in subgroups after biochemistry and serology. Contrib Microbiol Immunol (1979) 1.02
Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints. J Rheumatol (1989) 1.02
Studies on Yersinia enterocolitica isolated from swine and dogs. Acta Pathol Microbiol Scand B (1979) 1.01
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). Arthritis Res (2001) 1.01
Diffuse idiopathic skeletal hyperostosis (DISH) causing spinal stenosis and sudden paraplegia. J Rheumatol (1983) 0.99
[Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer]. Rev Mal Respir (2006) 0.98
Alkaptonuria and ochronosis in three siblings. Ascorbic acid treatment monitored by urinary HGA excretion. Clin Exp Rheumatol (1988) 0.98
Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmö, Sweden. Scand J Rheumatol (2007) 0.98
A problem-based education program for patients with rheumatoid arthritis: evaluation after three and twelve months. Arthritis Care Res (1997) 0.97
Factors related to the progression of joint destruction in rheumatoid arthritis. Scand J Rheumatol (1984) 0.97
HL-A27 and reactive arthritis in an outbreak of salmonellosis. Tissue Antigens (1975) 0.97
Studies on non-specific antistreptolysin o titre. 1. The influence of serum beta-lipoproteins on the non-specific antistreptolysin o titre. Acta Pathol Microbiol Scand (1966) 0.97
[The Malmo model for private and public rheumatological outpatient care. Cooperation makes it possible to introduce disease modifying treatment quickly]. Lakartidningen (2001) 0.96
Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale. Ann Rheum Dis (2001) 0.93
Immunoglobulins in the course of viral hepatitis and in cholestatic and obstructive jaundice. Acta Med Scand (1968) 0.93
Erythema nodosum associated with infection with Yersinia enterocolitica. Scand J Infect Dis (1969) 0.92
Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis? Br Med J (Clin Res Ed) (1987) 0.90
Prism adaptation improves spatial dysgraphia following right brain damage. Neuropsychologia (2006) 0.89
Susceptibility to mecillinam and other antibiotics of 28 O-serotypes of Yersinia enterocolitica. J Antimicrob Chemother (1981) 0.89
Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus. Br J Rheumatol (1997) 0.89
Chloroquine treatment in rheumatoid arthritis. Correlation of clinical response to plasma protein changes and chloroquine levels. Scand J Rheumatol (1978) 0.88
HLA-antigen b27 in cases with joint affections in an outbreak of salmonellosis. Scand J Infect Dis (1976) 0.88
Clinical manifestations of infection with Yersinia enterocolitica in children. Acta Paediatr Scand (1974) 0.87
Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts. Arthritis Rheum (1998) 0.87
Alpha-1-antitrypsin phenotypes and rheumatic diseases. Lancet (1977) 0.87
Cyclofenil versus placebo in progressive systemic sclerosis. A one-year double-blind crossover study of 27 patients. Acta Med Scand (1981) 0.86
Inhibition of in vivo leucocyte migration by NSAIDs. Clin Exp Rheumatol (1985) 0.85
Inverse relation between plasma concentration of von Willebrand factor and CrEDTA clearance in systemic sclerosis. J Rheumatol (1994) 0.85
[Five year survival for lung cancer patients managed in general hospitals]. Rev Mal Respir (2009) 0.85
Intraarticular corticosteroid injection into rheumatoid arthritis knees improves extensor muscles strength. Rheumatol Int (1990) 0.84
Serological activity in myeloma type golbulins. Clin Exp Immunol (1966) 0.84
Studies on non-specific antistreptolysin O titre. 2. Comparison of specific and non-specific antistreptolysins by gelfiltration and dextran sulphate precipitation. Acta Pathol Microbiol Scand (1965) 0.84
Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis (1996) 0.83
Studies on the macroglobulins of human serum. 3. Quantitative aspects related to cold agglutinins. Blood (1967) 0.83
New insight into joint damage from analysis of released biochemical markers. Br J Rheumatol (1994) 0.83
Inverse effect on the serum levels of gamma-G- and gamma-M-globulins after prednisone treatment of lupoid hepatitis. Clin Exp Immunol (1967) 0.83
[Primary lung cancer in elderly subjects in France]. Rev Mal Respir (2004) 0.82
Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Ann Rheum Dis (2001) 0.82
Low-temperature near-field spectroscopy of CdTe quantum dots. J Microsc (2001) 0.82
Reduced in vivo leucocyte migration and elastase and lysozyme concentrations in skin chamber experiments with piroxicam in healthy volunteers. Clin Exp Rheumatol (1986) 0.82
Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension. Ann Rheum Dis (2002) 0.82
Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold. Br J Rheumatol (1998) 0.81
Acute and long-term complications of corticosteroid pulse therapy. Scand J Rheumatol Suppl (1984) 0.81
[Yersiniosis enterocolitica]. Lakartidningen (1973) 0.81
Human arthritic synovial fluid influences proteoglycan biosynthesis and degradation in organ culture of bovine nasal cartilage. Coll Relat Res (1988) 0.80
Plasma levels of beta 2-microglobulin in rheumatoid arthritis. Ann Rheum Dis (1980) 0.80
Studies on the macroglobulins of human serum. II. Heterogeneity of antigenic determinants among M-components in Waldenström's macroglobulinemia. Acta Med Scand Suppl (1966) 0.79
Scandinavia and the Bone and Joint Decade 2000-2010. A timely initiative. Scand J Rheumatol (1999) 0.79
The attachment of certain gram negative bacteria to buccal epithelial cells from patients with Yersinia arthritis. Clin Exp Rheumatol (1985) 0.78
Altered dermatan sulfate proteoglycan synthesis in fibroblast cultures established from skin of patients with systemic sclerosis. J Rheumatol (1996) 0.78
[Primary bronchial carcinoma in elderly subjects in France]. Rev Mal Respir (2003) 0.78
HIV prevalence and risk behaviour among intravenous drug users attending HIV counselling and testing centres in Paris. Addiction (1995) 0.78
Cineradiography identifies esophageal candidiasis in progressive systemic sclerosis. Clin Exp Rheumatol (1989) 0.78
Listeriosis during pregnancy and neonatal period in Sweden 1958--1974. Acta Paediatr Scand (1979) 0.78
Demographic and behavioral predictors of knowledge and HIV seropositivity: results of a survey conducted in three anonymous and free counselling and testing centers. Eur J Epidemiol (1997) 0.78
Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related. J Autoimmun (1988) 0.78
Immunoglobulin changes in the course of infectious mononucleosis. Scand J Haematol (1968) 0.78
Joint capsular stiffness in knee arthritis. Relationship to intraarticular volume, hydrostatic pressures, and extensor muscle function. J Rheumatol (1989) 0.78
The search for laboratory measures of outcome in rheumatoid arthritis. Baillieres Clin Rheumatol (1992) 0.78